109 related articles for article (PubMed ID: 4051690)
1. [Synthesis of phosphono analogs of 2-O-acetyl-1-O-hexadecyl(octadecyl)-sn-3-glycerylphosphorylcholine (platelet-activating factor)].
Disselnkötter H; Lieb F; Oediger H; Wendisch D
Arch Pharm (Weinheim); 1985 Aug; 318(8):695-700. PubMed ID: 4051690
[No Abstract] [Full Text] [Related]
2. [Synthesis of 1-(1-alkenyl)-2-acetyl-sn-glycero-3-phosphocholines, the aldehyded analogs of platelet activating factor].
Gordeev KIu; Serebrennikova GA; Evstigneeva RP
Bioorg Khim; 1987 Jan; 13(1):109-12. PubMed ID: 3566815
[TBL] [Abstract][Full Text] [Related]
3. The enantiomer and the positional isomer of platelet-activating factor.
Tence M; Coëffier E; Polonsky J; Benveniste J
Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
[TBL] [Abstract][Full Text] [Related]
4. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.
Kloprogge E; Hasselaar P; Akkerman JW
Biochem J; 1986 Sep; 238(3):885-91. PubMed ID: 3800968
[TBL] [Abstract][Full Text] [Related]
5. Phosphono-platelet activating factor I. Synthesis of 1-O-hexadecyl-2-O-acetyl-glyceryl-3-(2-trimethyl ammonium-methyl) phosphonate and its platelet activating potency.
Moschidis MC; Demopoulos CA; Kritikou LG
Chem Phys Lipids; 1983 Jul; 33(1):87-92. PubMed ID: 6627527
[TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine). Activity of analogs lacking oxygen at the 2-position.
Wykle RL; Surles JR; Piantadosi C; Salzer WL; O'Flaherty JT
FEBS Lett; 1982 May; 141(1):29-32. PubMed ID: 7084476
[No Abstract] [Full Text] [Related]
7. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
Grigoriadis G; Stewart AG
Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
[TBL] [Abstract][Full Text] [Related]
8. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
Hofmann B; Ostermann G; Kertscher HP; Till U
Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200
[TBL] [Abstract][Full Text] [Related]
9. Effects of a thio analog of platelet-activating factor on platelet aggregation and adenosine 3',5'-monophosphate concentration in hepatocyte suspensions and in platelets. A comparison with the naturally occurring compound.
Hillmar I; Muramatsu T; Zöllner N
Hoppe Seylers Z Physiol Chem; 1984 Jan; 365(1):33-41. PubMed ID: 6325321
[TBL] [Abstract][Full Text] [Related]
10. Desorption chemical ionization mass spectrometry of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines and analogues.
Thomas MJ; Samuel M; Wykle RL; Surles JR; Piantadosi C
J Lipid Res; 1986 Feb; 27(2):172-6. PubMed ID: 3958619
[TBL] [Abstract][Full Text] [Related]
11. Effect of synthetic phospholipids on platelet aggregation and serotonin release.
Söling U; Eibl H; Nagel GA; Unger C
Lipids; 1987 Nov; 22(11):868-70. PubMed ID: 3444380
[TBL] [Abstract][Full Text] [Related]
12. Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine.
Billah MM; Johnston JM
Biochem Biophys Res Commun; 1983 May; 113(1):51-8. PubMed ID: 6407483
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
Kertscher HP; Ostermann G
Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334
[TBL] [Abstract][Full Text] [Related]
14. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor.
Rosario-Jansen T; Jiang RT; Tsai MD; Hanahan DJ
Biochemistry; 1988 Jun; 27(13):4619-24. PubMed ID: 3167004
[TBL] [Abstract][Full Text] [Related]
15. New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures.
Heymans F; Michel E; Borrel MC; Wichrowski B; Godfroid JJ; Convert O; Coeffier E; Tence M; Benveniste J
Biochim Biophys Acta; 1981 Nov; 666(2):230-7. PubMed ID: 7306563
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
Nishihira J; Ishibashi T; Imai Y
J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of trideuterated O-alkyl platelet activating factor and lyso derivatives.
Prakash C; Saleh S; Taber DF; Blair IA
Lipids; 1989 Sep; 24(9):786-92. PubMed ID: 2586235
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of bioisosteric O-carba-analogues of platelet activating factor (PAF).
Nakamura N; Miyazaki H; Ohkawa N; Koike H; Sada T; Asai F; Kobayashi S
Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2452-5. PubMed ID: 6488414
[No Abstract] [Full Text] [Related]
19. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
Ostermann G; Kertscher HP; Till U
Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
[TBL] [Abstract][Full Text] [Related]
20. [Effect of sn-2-acetylated analogs of phosphatidalic acid on release and aggregation of human platelets].
Muzia GI; Kulikov VI
Biokhimiia; 1996 Mar; 61(3):455-60. PubMed ID: 8724603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
